Abstracts

Biology and Microenvironment

  • T001 (0006)
    CK2A is overexpressed, active and targetable with silmitasertib In classical Hodgkin Lymphoma
    Abstract Talk in Molecular Pathogenesis (Saturday 08:45–10:15)
    View full abstract at Hemasphere…
    • Visentin A.
    • Frezzato F.
    • Severin F.
    • Pizzi M.
    • Martini V.
    • Raggi F.
    • Imbergamo S
    • Scomazzon E
    • Pravato S
    • Manni S.
    • Facco M.
    • Carlo-Stella C.
    • Semenzato G.
    • Piazza F.
    • Trentin L.
  • T002 (0076)
    Low B-cell content at diagnosis is associated with adverse outcome in advanced stage classical Hodgkin Lymphoma
    Abstract Talk in Molecular Pathogenesis (Saturday 08:45–10:15)
    • Ron D. Jachimowicz
    • Luise Pieper
    • Artur Gontarewicz
    • Annette Plütschow
    • Heinz Haverkamp
    • Sarah Reinke
    • Christoph Thorns
    • Martin Leo Hansmann
    • Peter Möller
    • Andreas Rosenwald
    • Harald Stein
    • Christian Kohler
    • Gunther Glehr
    • H. Christian Reinhardt
    • Peter Borchmann
    • Bastian v. Tresckow
    • Michael Altenbuchinger
    • Rainer Spang
    • Andreas Engert
    • Wolfram Klapper
  • T003 (0171)
    ROR-1 receptor is a potential therapeutic target in classical Hodgkin Lymphoma
    Abstract Talk in Molecular Pathogenesis (Saturday 08:45–10:15)
    • Louloudenia Velentza
    • Ioannis Zerdes
    • Amir Hossein Danesh Manesh
    • Nikolaos Tsesmetzis
    • Mohammad Hojat-Farsangi
    • Amineh Ghaderi
    • Elias Drakos
    • Marzia Palma
    • Anders Österborg
    • Håkan Mellstedt
    • George Z. Rassidakis
  • T008 (0050)
    Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma patients to determine pathogenic mechanisms and monitor therapy
    Abstract Talk in Biology & Microenvironment (Sunday 10:30–12:00)
    View full abstract at Hemasphere…
    • Andreas Bräuninger
    • Ann-Kathrin Desch
    • Kristin Kunze
    • Ante Boten
    • Alexander Brobeil
    • Mathias Rummel
    • Lars Kurch
    • Thomas Georgi
    • Regine Kluge
    • Christine Mauz-Körholz
    • Dieter Körholz
    • Stefan Gattenlöhner
  • T009 (0083)
    Circulating Tumor DNA as a Biomarker for the Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma
    Abstract Talk in Biology & Microenvironment (Sunday 10:30–12:00)
    View full abstract at Hemasphere…
    • Michael C. Jin
    • David M Kurtz
    • Mohammad Shahrokh Esfahani
    • Brian J. Sworder
    • Joseph Schroer-Martin
    • Joanne Soo
    • Cynthia Glover
    • Mark Roschewski
    • Wyndham Wilson
    • Ulrich Düehrsen
    • Andreas Hüttmann
    • Davide Rossi
    • Gianluca Gaidano
    • Jason Westin
    • Maximilian Diehn
    • Ranjana Advani
    • Ash A. Alizadeh
  • P019 (0158)
    Functional analysis of CD30 in Hodgkin and anaplastic large cell lymphoma cell lines by CRISPR/Cas9-mediated gene knockout
    Poster Pitch in Biology & Microenvironment (Sunday 10:30–12:00)
    View full abstract at Hemasphere…
    • Annika L. Weiß
    • Anna Lollies
    • Freya Kretzmer
    • Marc A. Weniger
    • Ralf Küppers
  • P021 (0168)
    Copy number aberrations in cell-free DNA of Hodgkin lymphoma
    Poster Pitch in Biology & Microenvironment (Sunday 10:30–12:00)
    • Lieselot Buedts
    • Thomas Tousseyn
    • Olivier Gheysens
    • Julio Finalet-Ferreiro
    • Luc Dehaspe
    • Gregor Verhoef
    • Sanne Smits
    • Joris Vermeesch
    • Peter Vandenberghe
  • T010 (0113)
    Clinical validation of an extracellular vesicle associated miRNA detection assay to monitor therapy response in classical Hodgkin lymphoma patients
    Abstract Talk in Biology & Microenvironment (Sunday 10:30–12:00)
    View full abstract at Hemasphere…
    • E.E.E. Drees
    • M.A.J. van Eijndhoven
    • I. Ciocanea-Teodorescu
    • N.J. Groenewegen
    • L.I. Prins
    • X. Tran
    • A. Valles
    • D. Koppers-Lalic
    • E. Aparicio
    • M. Hackenberg
    • D. de Jong
    • J.M. Zijlstra
    • and D.M. Pegtel
  • T011 (0162)
    Molecular Mechanisms in the Pathogenesis of Composite Lymphomas
    Abstract Talk in Biology & Microenvironment (Sunday 10:30–12:00)
    View full abstract at Hemasphere…
    • Anna Lollies
    • Markus Schneider
    • Sylvia Hartmann
    • Stephan Mathas
    • Enrico Tiacci
    • Marc Andree Weniger
    • Patricia Johansson
    • Jan Dürig
    • Ludger Klein-Hitpass
    • Martin-Leo Hansmann and Ralf Küppers
  • P004 (0011)
    Array-based DNA methylome analyses of classical Hodgkin lymphoma
    View full abstract at Hemasphere…
    • Vogt J.
    • Kretzmer H.
    • Ammerpohl O.
    • Vallés Uriate L.
    • Drexler HG.
    • Wagener R.
    • López C.
    • Siebert R.
  • P005 (0036)
    The role of TCF3 in classical Hodgkin lymphoma
    View full abstract at Hemasphere…
    • Rianne Veenstra
    • Joost Kluiver
    • Lydia Visser
    • Arjan Diepstra and Anke van den Berg
  • P006 (0037)
    Recurrent exportin 1 mutations in patients with classical Hodgkin Lymphoma
    View full abstract at Hemasphere…
    • Almudena Navarro-Bailón
    • Cristina Jiménez
    • Sara Alonso-Álvarez
    • Alicia Antón
    • María Carmen Chillón
    • Miguel Alcoceba
    • María García-Álvarez
    • Isabel Prieto
    • Alejandro Medina
    • Verónica González-de-la-Calle
    • Marcos González
    • María Eugenia Sarasquete
    • Ramón García-Sanz
  • P007 (0043)
    TARC immunohistochemistry in the diagnosis of classical Hodgkin lymphoma
    View full abstract at Hemasphere…
    • Carlijn Veldman
    • Stefano Rosati
    • Anke van den Berg
    • Lydia Visser
    • Wouter Plattel
    • and Arjan Diepstra
  • P008 (0053)
    Whole-slide-image analysis of the tumormicronenvironment in classical Hodgkin Lymphoma
    View full abstract at Hemasphere…
    • Luise Pieper
    • Sarah Reinke
    • Ron Jachimowicz
    • Annette Plütschow
    • Andreas Engert
    • Wolfram Klapper
  • P009 (0069)
    CD2 is an important adhesion molecule in the initial interaction between Hodgkin Reed-Sternberg cells and rosetting T cells
    View full abstract at Hemasphere…
    • J. Veldman
    • A. van den Berg
    • L. Visser
    • A. Diepstra
  • P010 (0073)
    A new reliable and highly specific antibody to detect SOCS1 (Silencer of Cytokine Signaling 1).
    • Stephanie E. Weissinger
    • Malena Zahn
    • Kevin Mellert
    • Ralf Marienfeld
    • Gerhard Moldenhauer
    • Peter Möller.
  • P012 (0081)
    Soluble cytokines in Hodgkin lymphoma patients treated with a GHSG policy: an analysis of the Czech Hodgkin Lymphoma Study Group
    View full abstract at Hemasphere…
    • Vit Prochazka
    • Marie Lukasova
    • Eva Kriegova
    • Alice Sykorova
    • Heidi Mocikova
    • Tomas Papajik
    • David Belada
    • Jana Markova
    • Katerina Klaskova
    • Veronika Hanackova
    • Gabriela Gabcova
    • Zuzana Mikulková
    • and Pavla Stepankova
    • on behalf of the Czech Hodgkin Lymphoma Study Group
  • P013 (0088)
    Digital image analysis of the microenvironment in classical Hodgkin lymphoma comparing primary tumor and relapse
    View full abstract at Hemasphere…
    • Franziska Jochims¹
    • Sarah Kretschmer¹
    • Ron Jachimowicz²'³
    • Falko Fend⁴
    • German Ott⁵
    • Martin-Leo Hansmann⁶
    • Christoph Thorns⁷
    • Annette Plütschow³
    • Andreas Engert²'³
    • Wolfram Klapper¹
  • P014 (0098)
    CD47 is expressed on Hodgkin Reed Sternberg cells in Classical Hodgkin lymphoma.
    View full abstract at Hemasphere…
    • Alonso
    • Lopez-Pereira B
    • Corte
    • Alonso-Alvarez S
    • Fernandez-Vega I
    • García-Moro MA
    • Bernal
    • Alonso-Arias R
    • and Colado E
  • P015 (0100)
    Characterization of T-cell phenotypes with clinical significance in patients with classical Hodgkin lymphoma
    View full abstract at Hemasphere…
    • Kristiina Karihtala
    • Suvi-Katri Leivonen
    • Teijo Pellinen
    • Oscar Brück
    • Marja-Liisa Karjalainen-Lindsberg
    • Satu Mustjoki
    • and Sirpa Leppä
  • P016 (0104)
    Phenotypic characterization of circulating T and NK cells in Hodgkin lymphoma patients in relation to tumor burden and treatment
    • Tom A. Mulder
    • Kia Heimersson
    • Barbro Näsman-Glaser
    • Lotta Hansson
    • and Marzia Palma
  • P017 (0120)
    Immunologic Biomarkers of Response and Resistance to Brentuximab Vedotin in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
    View full abstract at Hemasphere…
    • Joo Y. Song
    • Wing C. Chan
    • Charles Warden
    • Xiwei Wu
    • Dennis D. Weisenburger
    • Robert Chen
    • Alex F. Herrera
  • P018 (0139)
    GATA3 expression distinguishes Classic Hodgkin lymphoma from Nodular lymphocyte Hodgkin lymphoma
    View full abstract at Hemasphere…
    • Sridhar Epari
    • Vidya R
    • Hasmukh Jain#
    • Bhausaheb Bagal#
    • Siddharth Laskar
    • Manju Sengar#
    • Sumeet Gujral and Tanuja Shet
  • P020 (0164)
    Extracellular ciruculating DNA in Hodgkins lymphoma patients: biological corellates and prognostic impact
    View full abstract at Hemasphere…
    • Dino Dujmović
    • Sandra Bašić Kinda
    • Ivo Radman
    • Goran Lauc
    • Ivana Ilić
    • Igor Aurer
  • P022 (0170)
    The Tumor Suppressor SAMHD1 is Downregulated by MYC in Classical Hodgkin Lymphoma
    • Ioanna Xagoraris
    • Theodoros Vassilakopoulos
    • PhD
    • Nikolas Herold
    • Nikolaos Tsesmetzis
    • MSc.
    • Joseph Khoury
    • Elias Drakos
    • and George Rassidakis
  • P031 (0145)
    Evaluation of CCL17 (TARC) as a diagnostic biomarker for classical Hodgkin lymphoma: interim results from the CANDEL study.
    View full abstract at Hemasphere…
    • Annette Lake
    • Iain J Nixon
    • Paula Beattie
    • Kim Ah-See
    • Dominic Culligan
    • Nicholas Heaney
    • Pam McKay
    • Omar J Hilmi
    • and Ruth F Jarrett

Immunotherapy - Biology and Mechanisms

Early Stages

  • T012 (0066)
    Relapses in early PET-negative stage I/II Hodgkin Lymphoma (HL) after combined modality treatment or chemotherapy only in the EORTC/LYSA/FIL H10 trial
    Abstract Talk in Early Stages (Sunday 14:00–15:30)
    • Valeria Fiaccadori
    • Anouk Neven
    • Anne-Claire Gac
    • Luigi Rigacci
    • Theo Girinsky
    • Michel Meignan
    • Martin Hutchings
    • Annibale Versari
    • Oumedaly Reman
    • Umberto Ricardi
    • Marc Andre
    • Massimo Federico
    • John Raemaekers
    • Catherine Fortpied
  • T013 (0095)
    Maximum tumour dimension at baseline is associated with event-free survival in PET negative patients with stage IA/IIA Hodgkin lymphoma in the UK NCRI RAPID trial
    Abstract Talk in Early Stages (Sunday 14:00–15:30)
    View full abstract at Hemasphere…
    • Tim Illidge
    • Elizabeth Phillips
    • Nicholas Counsell
    • Ruth Pettengell
    • Peter Johnson
    • Dominic Culligan
    • Bilyana Popova
    • Laura Clifton-Hadley
    • Andrew McMillan
    • Peter Hoskin
    • Sally Barrington
    • John Radford
  • P027 (0101)
    Cardiovascular Radiation Dosimetry and Predicted Cardiovascular Risks from Involved Field Radiotherapy within the UK ‘RAPID’ Trial in Early Low-Risk Hodgkin Lymphoma
    Poster Pitch in Early Stages (Sunday 14:00–15:30)
    View full abstract at Hemasphere…
    • Dr David J. Cutter
    • MD DPhil
    • Dr Johanna Ramroth
    • DPhil
    • Patricia Diez
    • MSc
    • Andy Buckle
    • David Kennedy
    • Bilyana Popova
    • Laura Clifton-Hadley
    • PhD
    • Prof Tim Illidge
    • MD PhD
    • Prof Sarah C. Darby
    • Prof John Radford
  • P029 (0142)
    Quality Assurance of Involved-Node Radiotherapy: First Results of the HD17-Trial of the GHSG
    Poster Pitch in Early Stages (Sunday 14:00–15:30)
    View full abstract at Hemasphere…
    • Kriz J
    • Baues C
    • Oertel M
    • Engenhart-Cabillic R
    • Herfarth K
    • Lukas P
    • Marnitz-Schulze S
    • Schmidberger H
    • Vordermark D
    • Haverkamp U
    • Engert A
    • Eich HT
  • T014 (0118)
    Multicentric Italian Experience in Treatment of Nodular Lymphocyte Predominant Hodgkin lymphoma (NLPHL) in the Rituximab Era
    Abstract Talk in Early Stages (Sunday 14:00–15:30)
    View full abstract at Hemasphere…
    • Manuel Gotti
    • Roberta Sciarra
    • Alessandro Pulsoni
    • Francesco Merli
    • Chiara Rusconi
    • Barbara Botto
    • Alessandro Re
    • Andrea Rossi
    • Luigi Rigacci
    • Alberto Fabbri
    • Marina Liberati
    • Michele Merli
    • Luca Nassi
    • Carmelo Carlo Stella
    • Maurizio Bonfichi
    • Valentina Zoboli
    • Germana Tartaglia
    • Isabel Alvarez
    • Erika Meli
    • Maura Nicolosi
    • Daniela Dalceggio
    • Silvia Ferrari
    • Benedetta Puccini
    • Emanuele Cencini
    • Viviana Apoll
  • T015 (0124)
    Brentuximab Vedotin and AVD Chemotherapy followed by Reduced Dose/Volume Radiotherapy in Patients with Early Stage, Unfavorable Hodgkin Lymphoma
    Abstract Talk in Early Stages (Sunday 14:00–15:30)
    View full abstract at Hemasphere…
    • Joanna C. Yang
    • Anita Kumar
    • Carla Casulo
    • Ranjana Advani
    • Elizabeth Budde
    • Paul M. Barr
    • Connie L. Batlevi
    • Philip Caron
    • Robert Chen
    • Louis S. Constine
    • Amanda Courtien
    • Savita V. Dandapani
    • Pamela Drullinsky
    • Jonathan W. Friedberg
    • Audrey Hamilton
    • Paul A. Hamlin
    • Richard T. Hoppe
    • Steven M. Horwitz
    • Andrew Intlekofer
    • Oscar Lahoud
    • Matthew J. Matasar
    • Alison J. Moskowitz
    • Ariela Noy
    • Maria L. Palomba
    • Carol S. Portlock
    • Heiko Schöder
    • David J. Straus
    • Santosh Vardhana
    • Shreya
  • P023 (0003)
    Conventional vs multifractionation at radiotherapy for above diaphragm stage II Hodgkin Lymphoma: 30-year experience of single Center
    View full abstract at Hemasphere…
    • Ilyin N. V.
    • Vinogradova J. N.
    • Ivanova E. I.
  • P024 (0009)
    Limited-Stage Hodgkin Lymphoma: Minimizing Toxicity
    View full abstract at Hemasphere…
    • David J. Straus
    • M.D.
  • P025 (0033)
    Metabolic tumor volume by positron emission tomography ⁄ computed tomography for deciding the therapeutic modality in patients with early stage Hodgkin’s lymphoma
    View full abstract at Hemasphere…
    • Joo-Seop Chung
    • Moo-Gon Song
    • Do-Young Kim
    • Ho-Jin Shin
    • Seong-Jang Kim
    • Young-Don Joo
  • P026 (0057)
    Interim- PET Results for Prognosis in Adults with Hodgkin Lymphoma: A Prognostic Factor Exemplar Review (Preliminary Results)
    View full abstract at Hemasphere…
    • Angela Aldin
    • Marialena Trivella
    • Lise J Estcourt
    • Gary Collins
    • Karel Moons
    • Andreas Engert
    • Bastian von Tresckow
    • Carsten Kobe
    • Farid Foroutan
    • Nina Kreuzberger
    • Nicole Skoetz
  • P028 (0102)
    Patterns of Relapse in Patients Treated for Early Stage Classical Hodgkin Lymphoma in the Modern Era
    View full abstract at Hemasphere…
    • Karin Nielsen MD
    • Maja V. Maraldo MD
    • PhD
    • Anne Kiil Berthelsen MD
    • Annika Loft MD
    • Peter Meidahl Petersen MD
    • Marianne C. Aznar
    • Ivan Richter Vogelius
    • DMSc
    • Peter Brown
    • Lena Specht MD
  • P030 (0143)
    Once-a-cycle vs. daily G-CSF in early-unfavorable stages of Hodgkin Lymphoma treated with BEACOPP escalated followed by ABVD
    View full abstract at Hemasphere…
    • Michael Fuchs
    • Horst Müller
    • Dennis A. Eichenauer
    • Stefanie Kreissl
    • Andreas Engert
    • and Peter Borchmann
  • P050 (0075)
    Clinical Characteristics and Prognosis Analysis of Early-Stage Classical Hodgkin Lymphoma
    View full abstract at Hemasphere…
    • Jun Zhu M.D. PhD.
    • Yan-fei Liu M.D.
    • Meng Wu M.D.
    • Mingzi Yang M.D.
    • Aliya M.D.
    • Reyizha Rnuersulitan M.D.
    • Yuqin Song M.D.

Survivorship and Patients Perspective

  • T016 (0018)
    Employment situation among long-term Hodgkin lymphoma survivors in Europe: An analysis of patients from nine consecutive EORTC-LYSA trials
    Abstract Talk in Survivorship & Patients’ Perspective (Sunday 17:45–19:15)
    View full abstract at Hemasphere…
    • Maja V. Maraldo
    • Michal Kicinski
    • Marleen A.E. van der Kaaij
    • Francesco Giusti
    • Paul Meijnders
    • Berthe M.P. Aleman
    • John M.M. Raemaekers
    • Elisabeth C. Moser
    • Hanneke C. Kluin-Nelemans
    • Michele Spina
    • Christophe Fermé
    • Pauline Brice
    • Olivier Casasnovas
    • Aspasia Stamatoullas
    • Marc André
    • Fabien Le Bras
    • Catherine Fortpied
    • Jan Bogaerts
    • Michel Henry-Amar
    • & Lifang Liu
  • P036 (0023)
    Early-Stage Hodgkin Lymphoma (HL) in the Modern Era: Harnessing Simulation Modeling to Delineate Long-Term Patient Outcomes
    Poster Pitch in Survivorship & Patients’ Perspective (Sunday 17:45–19:15)
    View full abstract at Hemasphere…
    • Susan K. Parsons
    • Michael J. Kelly
    • Joshua T. Cohen
    • Sharon M. Castellino
    • Tara O. Henderson
    • Kara M. Kelly
    • Frank G. Keller
    • Tobi J. Henzer
    • Anita J. Kumar
    • Peter Johnson
    • Ralph M. Meyer
    • John Radford
    • John Raemaekers
    • David C. Hodgson
    • Andrew M. Evens
  • P060 (0122)
    The reciprocal relation between cancer-related fatigue and physical and psychosocial functioning in survivors of Hodgkin lymphoma
    Poster Pitch in Survivorship & Patients’ Perspective (Sunday 17:45–19:15)
    View full abstract at Hemasphere…
    • A. Mayer
    • N. Stadtbäumer
    • S. Kreissl
    • H. Müller
    • H. Görgen
    • P. Borchmann
  • T017 (0044)
    Is routine laboratory testing useful in detecting relapse in patients with classic Hodgkin lymphoma in first remission?
    Abstract Talk in Survivorship & Patients’ Perspective (Sunday 17:45–19:15)
    • Lynch RC
    • Sundaram V
    • Desai M
    • Henry S
    • Wood D
    • Daadi SE
    • Corbelli K
    • Rosenberg SA
    • Hoppe RT
    • Advani RH
  • T018 (0140)
    Contemporarily treated Hodgkin lymphoma patients have childbearing potential in line with matched comparators
    Abstract Talk in Survivorship & Patients’ Perspective (Sunday 17:45–19:15)
    View full abstract at Hemasphere…
    • Caroline E. Weibull
    • Anna L.V. Johansson
    • Sandra Eloranta
    • Karin E. Smedby
    • Magnus Björkholm
    • Paul C. Lambert
    • Paul W. Dickman
    • Ingrid Glimelius
  • P032 (0002)
    Audit of lymphoma patient group irradiated blood product policy compliance at a UK comprehensive cancer centre
    View full abstract at Hemasphere…
    • Jane Gibson
    • Sarah Wells
    • Sharon Jackson
    • Philip Higham
    • Deborah Seal
    • Kim Linton
  • P033 (0007)
    SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET
    View full abstract at Hemasphere…
    • Visentin A
    • Pravato S
    • Scomazzon E
    • Imbergamo S
    • Branca A
    • Gregianin M
    • Vio S
    • Boso C
    • Piazza F
    • Vianello F
    • Zambello R
    • Semenzato G
    • Trentin L
  • P034 (0021)
    Returning to school or work after Hodgkin lymphoma: An EORTC-LYSA cross-sectional study
    View full abstract at Hemasphere…
    • Maja V. Maraldo
    • Michal Kicinski
    • Marleen A.E. van der Kaaij
    • Francesco Giusti
    • Paul Meijnders
    • Berthe M.P. Aleman
    • John M.M. Raemaekers
    • Elisabeth C. Moser
    • Hanneke C. Kluin-Nelemans
    • Michele Spina
    • Christophe Fermé
    • Pauline Brice
    • Olivier Casasnovas
    • Aspasia Stamatoullas
    • Marc André
    • Fabien Le Bras
    • Catherine Fortpied
    • Jan Bogaerts
    • Michel Henry-Amar
    • & Lifang Liu
  • P035 (0022)
    Fatigue impairment in Hodgkin and non-Hodgkin lymphoma survivors: A joint EORTC-LYSA cross-sectional survey
    • Nicolas Mounier
    • Raphaël Busson
    • Marleen van der Kaaij
    • Catherine Thieblemont
    • Berthe Aleman
    • Aspasia Stamatoullas
    • John Raemaekers
    • Vincent Ribrag
    • Michele Spina
    • Hervé Tilly
    • Christophe Fermé
    • Corinne Haioun
    • René-Olivier Casasnovas
    • Hanneke Kluin-Nelemans
    • Michel Henry-Amar
  • P037 (0027)
    The pathway to diagnosis of Hodgkin Lymphoma in South Africa: the determinants and impact of diagnostic delay
    View full abstract at Hemasphere…
    • Antel K
    • Levetan C
    • Mohamed Z
    • Louw VJ
    • Oosthuizen J
    • Verburgh E
  • P038 (0029)
    Hepatitis B virus infection is not associated with poor prognosis in Hodgkin lymphoma patients: A case-control study
    View full abstract at Hemasphere…
    • Weiping Liu
    • Mingzi Yang
    • Meng Wu
    • Lingyan Ping
    • Yuqin Song
    • Jun Zhu
  • P039 (0030)
    Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients
    • Caroline E. Weibull
    • Magnus Björkholm
    • Ingrid Glimelius
    • Paul C. Lambert
    • Therese M. L. Andersson
    • Karin E. Smedby
    • Paul W. Dickman
    • Sandra Eloranta
  • P040 (0031)
    Clinicopathological features and prognosis of 387 cases with classical Hodgkin lymphoma from China
    View full abstract at Hemasphere…
    • Jun Zhu
    • Mingzi Yang
    • Meng Wu
    • Lingyan Ping
    • Aliya
    • Yanfei Liu
    • Reyizha Nuersulitan
    • Yuqin Song
  • P041 (0034)
    A study of patient and general practitioner (GP) views and experience of managed local follow-up of long term lymphoma survivors (ADAPT)
    View full abstract at Hemasphere…
    • Sally Taylor
    • Valerie Goode
    • Ellie White
    • Richard Cowan
    • Janelle Yorke
    • John Radford
  • P042 (0035)
    Anemia has a negative impact on the outcome of patients with Hodgkin lymphoma
    View full abstract at Hemasphere…
    • Weiping Liu
    • Mingzi Yang
    • Meng Wu
    • Lingyan Ping
    • Xiaopei Wang
    • Yuqin Song
    • Jun Zhu
  • P043 (0039)
    Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: A retrospective study of 27 cases
    View full abstract at Hemasphere…
    • Jun Zhu
    • Mingzi Yang
    • Meng Wu
    • Lingyan Ping
    • Aliya
    • Yanfei Liu
    • Reyizha Nuersulitan
    • Yuqin Song
  • P044 (0046)
    Investigation the role of adding a serum biomarker to interim PET/CT in Hodgkin lymphoma patients
    • Ádám Jóna
    • Kata Husi
    • Béla Nagy
    • Zsolt Fejes
    • Zsófia Miltényi
    • Árpád Illés
  • P045 (0047)
    Hyperlipoproteinemia and markers of atherosclerosis progression in long-term survivors of Hodgkin lymphoma in childhood or adolescence and in healthy controls
    View full abstract at Hemasphere…
    • Cepelova M.
    • Kruseova J.
    • Luks A.
    • Cepela P.
    • Potockova J.
    • Kraml P.
  • P046 (0052)
    No clinical signals of Drug – Drug interaction of NEPA (netupitant + palonosetron) in cHL patients receiving ABVD regimen: a single-center real life experience
    View full abstract at Hemasphere…
    • Vittorio Ruggero Zilioli
    • Periana Minga
    • Lara Crucitti
    • Erika Meli
    • Chiara Rusconi
    • Roberto Cairoli
  • P047 (0058)
    An Epidemiological Study of Hodgkins Lymphoma from a single tertiary care centre in India with study of disease outcome
    View full abstract at Hemasphere…
    • Dr. Ankita Sen
    • Dr. T.K. Dolai
    • Dr. S.N. Baul
    • Dr. P.K. Mandal
    • Dr. R. De
    • Dr. S. Dutta
    • Dr. P. Chakrabarti
  • P048 (0065)
    Mature oocytes cryopreservation: a feasible fertility preservation technique in adult Hodgkin lymphoma female patients.
    View full abstract at Hemasphere…
    • Viviani S
    • Somigliana E
    • Filippi F
    • Landi F
    • Paffoni A
    • Mangili G
    • Mazza R
    • Papaleo E
    • Sigismondi C
    • Devizzi L
    • Dodero A
    • Farina L
    • Corradini P
  • P049 (0072)
    Results of cardiovascular screening in the BETER survivorship care initiative for Hodgkin lymphoma
    View full abstract at Hemasphere…
    • S.R. Pereboom
    • A. Nijdam
    • B.M.P. Aleman
    • R.W.M. van der Maazen
    • J.M. Zijlstra
    • R.J. de Weijer
    • M.B. van ’t Veer
    • J.M.M. Raemaekers
    • F.E. van Leeuwen
    • on behalf of the BETER consortium
  • P051 (0080)
    Cardiovascular disease risk after treatment-induced premature ovarian insufficiency in female survivors of Hodgkin lymphoma
    View full abstract at Hemasphere…
    • Berthe M.P. Aleman
    • PhD
    • Inge M. Krul
    • MSc
    • Annemieke W.J. Opstal – van Winden
    • Cécile P.M. Janus
    • Laurien A. Daniëls
    • Y. Appelman
    • Angela H.E.M. Maas
    • Frederika A. van Nimwegen
    • Simone de Vries
    • Michael Hauptmann
    • Katarzyna Jóźwiak
    • and Flora E. van Leeuwen
  • P052 (0082)
    Combined prognostic role of biomarkers and PET/CT in patients with Hodgkin lymphoma
    • Kata Husi
    • Árpád Illés
    • Béla Nagy
    • Zsolt Fejes
    • Judit Bedekovics
    • Zsófia Miltényi
  • P053 (0091)
    NEUTROPHIL TO LYMPHOCITE RATIO PREDICTS OVERALL SURVIVAL IN NEWLY DIAGNOSED HODGKIN LYMPHOMA PATIENTS - SINGLE CENTRE EXPERIENCE
    • Jelena Hajder
    • Natasa Stanisavljević
    • Dragomir Marisavljević
    • Vladimir Jurišić
    • Olivera Marković
    • Radmila Zivković
  • P054 (0092)
    Pregnancy in patients in complete remission after Hodgkin Lymphoma: clinical features and outcome.
    View full abstract at Hemasphere…
    • Francesco Gaudio
    • Claudia Nardelli
    • Tommasina Perrone
    • Filomena Emanuela Laddaga
    • Giorgina Specchia
  • P055 (0096)
    Health-Related Quality of Life (HRQL) Trajectories during Treatment for Advanced Stage Pediatric Hodgkin Lymphoma (HL)
    View full abstract at Hemasphere…
    • Angie Mae Rodday
    • PhD
    • Susan K Parsons
    • MRP
    • Rizvan Bush
    • Qinglin Pei
    • Rachael Curtis
    • Frank Keller
    • Kara Kelly
    • Tara Henderson
    • MPH
    • Sharon M Castellino
    • MSc
  • P056 (0097)
    Cognitive Dysfunction after Treatment for Hodgkin lymphoma
    View full abstract at Hemasphere…
    • Ferenc Magyari
    • Tibor Ivánka
    • Anikó Égerházi
    • Zsófia Simon
    • Zsófia Miltényi
    • Karolina Kósa
    • Árpád Illés
  • P057 (0108)
    Cognitive impairments in patients with Hodgkin’s Lymphoma
    View full abstract at Hemasphere…
    • Vinokurova E.G.
    • Marchenko A.A.
    • Khrushchev S.O.
    • Olexenko L.V.
    • Rupchev G.E.
    • Vybornykh D.E.
    • Moiseeva T.N.
  • P058 (0109)
    Fertility in Hodgkin´s lymphoma patients after initial therapy at Santa Casa de São Paulo Medical School
    View full abstract at Hemasphere…
    • Maria Fernanda Evangelista Simões
    • Gilnara Fontinelle Silva
    • Thaís Rodrigues da Cunha Fischer
    • Carlos Sérgio Chiattone
    • Sergio Costa Fortier
    • Talita Máira Bueno da Silveira da Rocha
  • P059 (0114)
    AA Amyloidosis Causing Nephrotic Syndrome in Two Patients with Hodgkin Lymphoma
    View full abstract at Hemasphere…
    • Ayse Salihoglu
    • Tugrul Elverdi
    • Dilek Keskin
    • Ahmet Emre Eskazan
    • Muhlis Cem Ar
    • Seniz Ongoren
    • Nukhet Tuzuner
    • Teoman Soysal
    • Zafer Baslar
  • P061 (0125)
    Chemotherapy-induced polyneuropathy in patients with Hodgkin lymphoma treated with vinca-alkaloids
    View full abstract at Hemasphere…
    • Smardova L
    • Vlckova E
    • Rajdova A
    • Raputova J
    • Bednarik J
    • Kral Z
  • P062 (0134)
    Long term health care use in relapsed and non-relapsed paediatric and young adult Hodgkin lymphoma patients – a population-based cohort study from Sweden and Denmark
    View full abstract at Hemasphere…
    • Ingrid Glimelius
    • Annika Englund
    • Klaus Rostgaard
    • Karin E. Smedby
    • Sandra Eloranta
    • Peter de Nully Brown
    • Christoffer Johansen
    • Peter Kamper
    • Gustaf Ljungman
    • Lisa Lyngsie Hjalgrim
    • Henrik Hjalgrim
  • P063 (0144)
    Cognitive impairment, structural and functional brain morphological sequelae of Hodgkin lymphoma treatment. First interim results of ongoing translational study.
    View full abstract at Hemasphere…
    • Tomas Kozak
    • Jiri Horacek
    • Heidi Mocikova
    • Lubica Gaherova
    • Dan Fayette
    • Lucie Geislerova
    • Ivana Karlova
    • Jana Markova
  • P064 (0146)
    Cause-specific mortality among Hodgkin lymphoma survivors up to 35 years after treatment
    View full abstract at Hemasphere…
    • Simone de Vries
    • Michael Schaapveld
    • Pieternella J. Lugtenburg
    • Laurien A. Daniëls
    • Eefke J. Petersen
    • Josée M. Zijlstra
    • Gustaaf W. van Imhoff
    • Richard W.M. van der Maazen
    • Max Beijert
    • Anna M. van Eggermond
    • Leontien C.M. Kremer
    • Marieke W.J. Louwman
    • Marnix Lybeert
    • Jan Paul de Boer
    • Berthe M.P. Aleman
    • Flora E. van Leeuwen
  • P065 (0150)
    Elevated neutrophil-to-monocyte ratio is associated with decreased overall survival at 5 years in classic Hodgkin lymphoma
    View full abstract at Hemasphere…
    • D. Neves
    • A. Roque
    • C. Afonso
    • A. Pinto
    • D. Mota
    • R. Guilherme
    • M. Gomes
    • L. Ribeiro
  • P066 (0154)
    eBEACOPP FOR FRONT-LINE TREATMENT OF PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA (cHL) IN THE REAL WORLD SETTING
    View full abstract at Hemasphere…
    • Sandra Basic-Kinda
    • Dino Dujmovic
    • Ivo Radman
    • Martina Moric Peric
    • Ida Hude
    • Nadira Durakovic
    • Marijo Vodanovic
    • Margareta Dobrenic
    • Marko Kralik
    • Lea Galunic-Bilic
    • Snjezana Dotlic
    • Igor Aurer

Advanced Stages

  • T019 (0026)
    Potential impact of consolidation radiation therapy for advanced Hodgkin Lymphoma: a secondary modeling analysis of SWOG S0816
    Abstract Talk in Advanced Stages (Monday 07:30–09:00)
    • Chul S. Ha
    • Hongli Li
    • Heiko Schoder
    • Chelsea Pinnix
    • Elizabeth Brem
    • Nancy Bartlett
    • Andrew Evens
    • Eric Hsi
    • Lisa Rimsza
    • John P. Leonard
    • Brad S. Kahl
    • Michael LeBlanc
    • Sonali Smith
    • Louis Constine
    • Jonathan W. Friedberg
  • T020 (0067)
    Baseline PET features as predictors of outcome in advanced HL : A prospective evaluation of UK patients in the RATHL trial (CRUK/07/033)
    Abstract Talk in Advanced Stages (Monday 07:30–09:00)
    • C Guezennec
    • AA Kirkwood
    • LC Pike
    • P Patrick
    • C Burton
    • F Miall
    • L Stevens
    • L Clifton-Hadley
    • J Radford
    • PW Johnson
    • SF Barrington
  • T021 (0147)
    B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)ne) in older patients with advanced-stage Hodgkin lymphoma: results of a phase II intergroup trial by the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG)
    Abstract Talk in Advanced Stages (Monday 07:30–09:00)
    View full abstract at Hemasphere…
    • Alexander Fosså
    • Boris Böll
    • Helen Goergen
    • Peter Kamper
    • Sirpa Leppä
    • Daniel Molin
    • Julia Meissner
    • Ellen Ritter
    • Jacob Haaber
    • Martin Hutchings
    • Michael Fuchs
    • Andreas Engert
    • Carsten Kobe
    • and Peter Borchmann
    • on behalf of the German Hodgkin Study Group and the Nordic Lymphoma Group
  • P068 (0008)
    JUNB, DUSP2, SGK1, CREBBP and SOCS1 are frequently mutated in T-cell/histiocyte rich large B-cell lymphoma
    View full abstract at Hemasphere…
    • Bianca Schuhmacher
    • Julia Bein
    • Tobias Rausch
    • Vladimir Benes
    • Thomas Tousseyn
    • Martine Vornanen
    • Maurilio Ponzoni
    • Randy Gascoyne
    • Christian Steidl
    • Ralf Küppers
    • Martin-Leo Hansmann
    • Sylvia Hartmann
  • P069 (0013)
    EVALUATION OF CLINICAL CHARACTERISTICS IN PATIENTS WITH INTERIM-PET NEGATIVE BUT POSITIVE END OF TREATMENT PET. DATA FROM THE PROSPECTIVE HD08-01 FIL STUDY.
    View full abstract at Hemasphere…
    • Rigacci L
    • Puccini B
    • Broccoli A
    • Evangelista A
    • Gioia D
    • Dona M
    • Kovalchuk S
    • Santoro A
    • Bonfichi M
    • Re A
    • Pagani C
    • Mannelli L
    • Zaja F
    • Vitolo U
    • Spina M
    • Pulsoni A
    • Nassi L
    • Stelitano C
    • Salvi F
    • Rusconi C
    • Tani M
    • Freilone R
    • Borsatti E
    • Zinzani PL.
  • P070 (0016)
    HIV-Associated Hodgkin Lymphoma at Groote Schuur Hospital, Cape Town, South Africa
    • Asso/Prof Jessica Opie Dr Luhan Swart Prof Nicolas Novitzky
  • P071 (0024)
    A Multicenter Phase 2 Study of Sequential Brentuximab Vedotin and AVD Chemotherapy for Older Patients with Untreated Classical Hodgkin Lymphoma
    View full abstract at Hemasphere…
    • Andrew M. Evens
    • Ranjana H. Advani
    • Irene Helenowski
    • PhD
    • Michelle Fanale
    • Sonali M. Smith
    • Borko Jovanovic
    • Gregory R. Bociek
    • Andreas K. Klein
    • Jane N. Winter
    • Leo I. Gordon
    • and Paul A. Hamlin
  • P072 (0038)
    FRONTLINE BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY EXHIBITS SUPERIOR MODIFIED PROGRESSION-FREE SURVIVAL VS CHEMOTHERAPY ALONE IN PATIENTS WITH STAGE III OR IV HODGKIN LYMPHOMA: PHASE 3 ECHELON-1 STUDY
    View full abstract at Hemasphere…
    • J. Radford
    • A. Gallamini
    • W. Jurczak
    • D.J. Straus
    • S.M. Ansell
    • W.S. Kim
    • A. Younes
    • S. Alekseev
    • Á. Illés
    • M. Picardi
    • E. Lech-Maranda
    • Y. Oki
    • T. Feldman
    • P. Smolewski
    • K.J. Savage
    • N.L. Bartlett
    • J. Walewski
    • R. Chen
    • R. Ramchandren
    • P.L. Zinzani
    • D. Cunningham
    • D.S. Heo
    • A. Rosta
    • N.C. Josephson
    • E. Song
    • J. Sachs
    • R. Liu
    • H. Jolin
    • D. Huebner
    • J.M. Connors
  • P073 (0045)
    BEACOPP escalated increases progression free survival in advanced classic Hodgkin lymphoma - a single centre real life experience
    View full abstract at Hemasphere…
    • A. Roque
    • C. Afonso
    • D. Neves
    • A. Pinto
    • D. Mota
    • R. Guilherme
    • M. Gomes
    • L. Ribeiro
  • P074 (0049)
    Accuracy of PET-based bone marrow assessment in patients with Hodgkin lymphoma: Results from the German Hodgkin Study Group trials HD16, HD17, and HD18
    • Conrad-Amadeus Voltin
    • Helen Goergen
    • Christian Baues
    • Michael Fuchs
    • Jasmin Mettler
    • Stefanie Kreissl
    • Jennifer Oertl
    • Bernd Klaeser
    • Alden Moccia
    • Alexander Drzezga
    • Andreas Engert
    • Peter Borchmann
    • Markus Dietlein
    • Carsten Kobe
  • P075 (0055)
    Should a bulky mediastinal mass larger than 7cm be considered an adverse prognostic factor in patients with advanced Hodgkin lymphoma and negative interim PET/CT?
    • Rebeca Lopez-Alonso
    • Tania Mashiach
    • Elinor Barzilai
    • Michal Weiler-Sagie
    • Eldad J Dann
  • P076 (0056)
    Clinical characteristics and treatment outcome of Nodular Lymphocyte Predominant Hodgkin's lymphoma with THRLBCL-like patterns.
    View full abstract at Hemasphere…
    • Dorokhina E.I.
    • Moiseeva T.N.
    • Kovrigina A.M.
    • Shupletsova I.A.
    • Al-Radi L.S.
    • Mangasarova Ya. K.
    • Goryacheva S.R.
  • P077 (0060)
    Comparison immunoarchitectural patterns of primary, extranodal and bone marrow lesions in nodular lymphocyte predominant Hodgkin lymphoma.
    View full abstract at Hemasphere…
    • Shupletsova I.
    • Kovrigina A.
    • Moiseeva T.
    • Dorokhina E.
  • P078 (0062)
    Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease
    View full abstract at Hemasphere…
    • Shunan Qi
    • Sarah Milgrom
    • Bouthaina Dabaja
    • Richard Tsang
    • Mario Levis
    • Umberto Ricardi
    • Eldad J Dann
    • Rebecca Lopez-Alonso
    • Andrea Ng
    • Joachim Yahalom
  • P079 (0070)
    German evidence-based guideline update on diagnosis, therapy and follow-up of adult Hodgkin lymphoma patients
    View full abstract at Hemasphere…
    • T. Jakob
    • M. Follmann
    • P. Borchmann
    • C. Baues
    • S. Sasse
    • P.J. Bröckelmann
    • S. Kreissl
    • D.A. Eichenauer
    • B. von Tresckow
    • C. Bürkle
    • A. Engert
    • N. Skoetz
  • P080 (0071)
    Analysis of outcomes and prognostic factors of 165 newly diagnosed patients with advanced classical Hodgkin lymphoma
    View full abstract at Hemasphere…
    • Jun Zhu
    • Aliya
    • MengWu
    • Mingzi Yang
    • Yanfei Liu
    • Reyizha Nuersulitan
    • Yuqin Song
  • P081 (0084)
    A Clinicopathologic Consensus Study of Gray Zone Lymphoma (GZL) with Features Intermediate Between Diffuse Large B-cell Lymphoma (DLBCL) and Classical HL (cHL)
    View full abstract at Hemasphere…
    • Monika Pilichowska
    • Stefania Pittaluga
    • PhD
    • Judith A Ferry
    • Jessica Hemminger
    • Hong Chang
    • Jennifer A. Kanakry
    • Laurie H. Sehn
    • Tatyana Feldman
    • Jeremy S. Abramson
    • Athena Kritharis
    • Francisco J. Hernandez-Ilizaliturri
    • Izidore S. Lossos
    • Oliver W. Press
    • Timothy S. Fenske
    • Jonathan W. Friedberg
    • Julie M. Vose
    • MBA
    • Kristie A. Blum
    • Deepa Jagadeesh
    • Bruce
  • P082 (0087)
    Clinical significance of autoimmune hemolytic anaemia and autoimmune thrombocytopenia during the course of Hodgkin lymphoma
    View full abstract at Hemasphere…
    • László Pinczés
    • Zsófia Miltényi
    • Ádám Jóna
    • Árpád Illés
  • P083 (0093)
    Low-dose consolidative mediastinal irradiation in accelerated hyperfractionated regimen for advanced Hodgkin lymphoma
    View full abstract at Hemasphere…
    • Bogatyreva T.I.
    • Pavlov V.V.
    • Terekhova A.Yu.
    • Shklyaev S.S.
    • Falaleeva N.A.
  • P084 (0094)
    Brentuximab-Vedotin and Bendamustine as first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).
    • GALLAMINI A
    • SCHIANO DE COLELLA JM
    • VIOTTI J
    • BIJOU F
    • RAMBALDI A
    • PERROT A
    • PATTI C
    • GASTAUD L
    • SORASIO R
    • DEBAIGT C
    • SCHIAPPA R
    • CHAMOREY E
    • VIVIANI S
    • and THYSS A
  • P085 (0112)
    Treatment toxicity in elderly Hodgkin lymphoma patients with advanced stage – multicenter retrospective data analysis from the Czech Republic
    View full abstract at Hemasphere…
    • SYKOROVA A.
    • MOCIKOVA H.
    • LUKASOVA M.
    • KOREN J.
    • STEPANKOVA P.
    • PROCHAZKA V.
    • BELADA D.
    • KLASKOVA K.
    • GAHEROVA L.
    • CHROUST K.
    • BURESOVA L.
    • MARKOVA J.
    • on behalf of the Czech Hodgkin Lymphoma Group
  • P086 (0129)
    Metabolic Tumour Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma
    • Jasmin Mettler
    • Horst Müller
    • Conrad-Amadeus Voltin
    • Christian Baues
    • Bernd Klaeser
    • Alden Moccia
    • Peter Borchmann
    • Andreas Engert
    • Georg Kuhnert
    • Alexander Drzezga
    • Markus Dietlein
    • Carsten Kobe
  • P087 (0135)
    HODGKIN LYMPHOMA IN HIV-POSITIVE PATIENTS: A SINGLE INSTITUTION RETROSPECTIVE STUDY
    View full abstract at Hemasphere…
    • Ammoni LC
    • Fasola C
    • De Francesco D
    • Micheli V
    • Bombonati G
    • Cattaneo MT
    • De Troia B
    • Ferrario S
    • Filipazzi V
    • Gambaro AR
    • Isabella L
    • Somma L
    • Tosca N
    • and Dalu D
  • P088 (0136)
    BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY IN PATIENTS WITH HIGH-RISK ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA (CHL): RESULTS OF PRESPECIFIED SUB-GROUP ANALYSES FROM THE ECHELON-1 STUDY
    View full abstract at Hemasphere…
    • Martin Hutchings
    • John Radford
    • Andrea Gallamini
    • Arpad Illes
    • Anna Sureda
    • Joseph M Connors
    • Alice Sykorova
    • Hirohiko Shibayama
    • Jeremy S Abramson
    • Neil Chua
    • Jonathan W Friedberg
    • Jan Koren
    • Ann Steward LaCasce
    • Lysiane Molina
    • Neil Josephson
    • Eric Song
    • Hina Jolin
    • Rachael Liu
    • Ashish Gautam
    • Stephen Ansell
  • P089 (0137)
    POPULATION PHARMACOKINETIC (POPPK) MODELING AND EXPOSURE-RESPONSE (ER) ASSESSMENT OF BRENTUXIMAB VEDOTIN EFFICACY AND SAFETY IN PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA (CHL) FROM THE PHASE 3 ECHELON-1 STUDY
    View full abstract at Hemasphere…
    • Ajit Suri
    • Diane R. Mould
    • Gregory Song
    • Graham Collins
    • Chris Endres
    • Jesus Gomez-Navarro
    • Karthik Venkatakrishnan
  • P090 (0141)
    PET-CT as a prognostic factor in patients with advanced stages in primary diagnosed Hodgkin Lymphoma (HL).
    • Ia. Pastushenko
    • T. Skrypets
    • O.Novosad
    • T. Kadnikova
    • A. Ashykhmin
    • Y. Kmetyuk
    • O. Karpova
    • L. Mykhalska
    • V. Kozlov
    • N. Novikov
    • E. Oliinichenko
    • N. Kostiukova
    • O. Tkachenko
    • O. Karnabeda
    • V. Stratienko
    • I.Kriachok
  • P091 (0159)
    SERUM sCD30 AND TARC DO NOT CORRELATE WITH PET-BASED RESPONSE ASSESSMENT IN PATIENTS (PTS) WITH STAGE III OR IV CLASSICAL HODGKIN LYMPHOMA (cHL): PHASE 3 ECHELON-1 STUDY OF BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY VS CHEMOTHERAPY ALONE
    View full abstract at Hemasphere…
    • Anna Sureda
    • Joseph M. Connors
    • Anas Younes
    • Andrea Gallamini
    • Stephen M. Ansell
    • Won S. Kim
    • Fiona Miall
    • Ashish Bajel
    • Wanda Knopinska-Posłuszny
    • Carol Anne Ogden
    • Shingo Kuroda
    • Rachael Liu
    • William L. Trepicchio
    • John Radford

Paediatric Hodgkin Lymphoma

  • T022 (0042)
    Survival by race/ethnicity in pediatric and adolescent patients with Hodgkin lymphoma: A pooled analysis of contemporary Children’s Oncology Group trials
    Abstract Talk in Pediatric HL (Monday 10:30–12:00)
    View full abstract at Hemasphere…
    • Justine M. Kahn
    • Kara M. Kelly
    • Qinglin Pei
    • Debra L. Friedman
    • Frank Keller
    • Rizvan Bush
    • Smita Bhatia
    • Tara O. Henderson
    • Cindy L. Schwartz
    • and Sharon M. Castellino
  • T023 (0106)
    Safety and early response to the first 2 cycles of Brentuximab Vedotin substituting vincristine in the OEPA / COPDAC regimen for high risk pediatric Hodgkin Lymphoma (HL)
    Abstract Talk in Pediatric HL (Monday 10:30–12:00)
    View full abstract at Hemasphere…
    • Monika L. Metzger
    • Jamie Flerlage
    • Matthew Krasin
    • Jörg M. Bartelt
    • Amy Billett
    • John K. Choi
    • PhD
    • Matthew Ehrhardt
    • Thomas Georgi
    • Dirk Hasenclever
    • Melissa Hudson
    • Sue C. Kaste
    • Regine Kluge
    • Dieter Körholz
    • Lars Kurch
    • Michael Link
    • Dietrich Stoevesandt
    • Christine Mauz-Körholz
  • T024 (0123)
    The feasibility of deep inspiration breath-hold in children: Results of the TEDDI pilot study
    Abstract Talk in Pediatric HL (Monday 10:30–12:00)
    View full abstract at Hemasphere…
    • Anni Young Lundgaard MD
    • Mirjana Josipovic MSc
    • Laura Rechner MSc
    • Pernille Envold Bidstrup PhD
    • Rune Hansen MSc
    • Sidsel Skov Damkjaer PhD
    • Morten Joergensen MD
    • Akmal Safwat MD
    • PhD
    • Lena Specht MD
    • DMSc
    • Lisa Hjalgrim MD
    • & Maja V. Maraldo MD
  • P092 (0019)
    Proteomic identification of plasma biomarkers in children and adolescents with recurrent Hodgkin Lymphoma
    View full abstract at Hemasphere…
    • Ombretta Repetto
    • Lara Mussolin
    • Caterina Elia
    • Lia Martina
    • Maurizio Bianchi
    • Salvatore Buffardi
    • Alesandra Sala
    • Roberta Burnelli
    • Maurizio Mascarin
    • Valli De Re
  • P093 (0028)
    HOPE to COPE with OPPA/COPP: Experience of GPOH HD-2002 study protocol in Pediatric Hodgkin Lymphoma in a tertiary care hospital in a resource constraint setting
    View full abstract at Hemasphere…
    • Patra PC
    • Phukan A
    • Chakrabarti P
    • Mandal PK
    • Dolai TK
    • De R
    • Baul S
  • P094 (0059)
    KEYNOTE-667: Phase 2, Open-Label Study of Pembrolizumab in Children and Young Adults With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) With Slow Early Response (SER) to Frontline Chemotherapy
    View full abstract at Hemasphere…
    • Christine Mauz-Körholz
    • Kara Kelly
    • Frank Keller
    • Akash Nahar
    • Arun Balakumaran
    • Lisa Giulino-Roth
  • P095 (0064)
    Hodgkin’s Lymphoma in adolescents: the Italian Association of Pediatric Hematology and Oncology (AIEOP) experience.
    View full abstract at Hemasphere…
    • R.Burnelli
    • G.Fiumana
    • M.Pillon
    • A.Sala
    • S.Buffardi
    • L.Vinti
    • M.Zecca
    • A.Garaventa
    • R.Rondelli
    • P.Muggeo
    • M.Provenzi
    • P.Farruggia
    • F.Rossi
    • E.Facchini
    • M.Mascarin
    • on behalf of the Italian Association of Pediatric Hematology and Oncology
  • P096 (0085)
    M1 macrophage polarization prevails in pediatric Hodgkin Lymphoma from Argentina regardless of Epstein Barr virus presence.
    View full abstract at Hemasphere…
    • Jimenez O
    • Barros MH
    • Cohen M
    • De Matteo E
    • Garcia Lombardi M
    • Preciado MV
    • Niedobitek G
    • Chabay P
  • P097 (0105)
    Implementing an effective pre-accrual quality assurance programme in the UK to ensure accuracy and consistency of radiotherapy contouring for paediatric Hodgkin’s Lymphoma within the EuroNet-PHL-C2 trial (EudraCT 2012-004053-88)
    View full abstract at Hemasphere…
    • P Díez
    • E Gallop-Evans
    • DJ Cutter
    • YC Chang
    • S Sivabalasingham
    • T Ajithkumar
    • DL Hedegaard
    • J Hayward
    • S Daw
  • P098 (0111)
    Treatment outcomes of Adolescent and young adult (AYA) Hodgkin lymphomas (HL): real world data from a tertiary care cancer centre
    • Manju Sengar
    • Hasmukh Jain
    • Sridhar Epari
    • Siddhartha Laskar
    • Bhausaheb Bagal
    • Tanuja Shet
    • Sumeet Gujral
    • Archi Agrawal
    • Venkatesh Rangarajan
    • Anant Gokarn
    • Nehal Khanna
    • Jayant Sastri Goda
    • Preeti Pawaskar
    • Raajit Chanana
  • P099 (0117)
    Survival by age in children and adolescents with Hodgkin lymphoma: A pooled analysis of Children’s Oncology Group (COG) trials
    View full abstract at Hemasphere…
    • Justine M. Kahn
    • Kara M. Kelly
    • Qinglin Pei
    • Debra L. Friedman
    • Frank Keller
    • Rizvan Bush
    • Smita Bhatia
    • Tara O. Henderson
    • Cindy L. Schwartz
    • and Sharon M. Castellino
  • P100 (0119)
    FAMHL: Genetic Study of Families with a High Frequency of classical Hodgkin Lymphoma
    View full abstract at Hemasphere…
    • Jamie E. Flerlage
    • Lynn Goldin
    • PhD
    • Mary L. McMaster
    • Charles Mullighan
    • MBBS
    • MSc
    • Kim Nichols
    • Chimene Kesserwan
    • Kayla Hamilton
    • Jamie Maciaszek
    • Evadnie Rampersaud
    • Gang Wu
    • Max Qian
    • Mariesha Williams
    • Monika L. Metzger
    • Jun J.Yang
  • P101 (0149)
    PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN PLUS AVD IN PEDIATRIC PATIENTS WITH ADVANCED STAGE NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA
    View full abstract at Hemasphere…
    • Anna Franklin
    • Marco Zecca
    • Flavio Augusto Luisi
    • Gregory Song
    • Ajit Suri
    • E. Jane Leonard
    • Franco Locatelli
  • P102 (0151)
    Durable remission for two patients with early relapse of Hodgkin lymphoma, treated with Brentuximab Vedotin plus Gemcitabine, without autologous stem cell transplantation: a report from the Children’s Oncology Group
    View full abstract at Hemasphere…
    • Ilia Buhtoiarov
    • Nkechi Mba
    • Crystal De Los Santos
    • Kathleen M McCarten
    • Monika L. Metzger
    • Qinglin Pei
    • PhD
    • Rizvan Bush
    • Kara M Kelly
    • Aron Flagg
    • Rabi Hanna
    • Peter Cole
  • P103 (0152)
    Stanford V chemotherapy and low dose radiotherapy for children and adolescents with unfavorable and intermediate risk Hodgkin lymphoma: results of a multi-institutional prospective clinical trial
    View full abstract at Hemasphere…
    • Monika L. Metzger
    • Amy L. Billett
    • Alison M. Friedmann
    • Matthew J. Krasin
    • Howard J. Weinstein
    • Eric C. Larsen
    • Karen J. Marcus
    • Chen Li
    • Zhaohua Lu
    • PhD
    • Sarah S. Donaldson
    • Michael P. Link
    • Melissa M. Hudson

Immunotherapy - Clinical

  • T025 (0005)
    Brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma: follow-up results from the phase 1/2 study
    Abstract Talk in Immunotherapy – Clinical (Monday 14:00–15:30)
    • Alex F. Herrera
    • Alison J. Moskowitz
    • Nancy L. Bartlett
    • Julie M. Vose
    • Radhakrishnan Ramchandren
    • Tatyana A. Feldman
    • Ann S. LaCasce
    • Stephen M. Ansell
    • Craig H. Moskowitz
    • Keenan Fenton
    • Kazunobu Kato
    • Faith Galderisi
    • Ranjana H. Advani
  • T026 (0025)
    A Phase II study of SHR-1210, an anti-PD-1 antibody, in Chinese Patients with Relapsed/Refractory classic Hodgkin Lymphoma
    Abstract Talk in Immunotherapy – Clinical (Monday 14:00–15:30)
    View full abstract at Hemasphere…
    • Jun Zhu
    • Jifeng Feng
    • Xinchuan Chen
    • Tongyu Lin
    • Junning Cao
    • Yanyan Liu
    • Yaozhong Zhao
    • Jie Jin
    • Haiwen Huang
    • Jianda Hu
    • Jun Luo
    • Liling Zhang
    • Hongwei Xue
    • Qingyuan Zhang
    • Yu Yao
  • P105 (0032)
    A phase II study of Pembrolizumab (PEM) followed by AVD for frontline treatment of classical Hodgkin Lymphoma (cHL): interim results
    Poster Pitch in Immunotherapy – Clinical (Monday 14:00–15:30)
    View full abstract at Hemasphere…
    • P. B. Allen
    • A. M. Evens
    • B. Pro
    • R. Karmali
    • H. Savas
    • G. Dillehay
    • A. Rademaker
    • B. Palmer
    • R. Advani
    • L. I. Gordon
    • J. N. Winter
  • T027 (0153)
    Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab in Patients with Hodgkin Lymphoma Aged ≥60 Years
    Abstract Talk in Immunotherapy – Clinical (Monday 14:00–15:30)
    • Jonathan W. Friedberg
    • Christopher A. Yasenchak
    • Gina D’Amato
    • Beata Holkova
    • Dipti Patel-Donnelly
    • Thomas Anderson
    • Timothy Larson
    • Yinghui Wang
    • Faith Galderisi
    • and Robert Chen
  • T028 (0163)
    Allogeneic stem cell transplantation (allo-SCT) for relapsed/refractory classical Hodgkin Lymphoma (cHL) patients treated with Nivolumab is associated with an unprecedented low relapse rate
    Abstract Talk in Immunotherapy – Clinical (Monday 14:00–15:30)
    View full abstract at Hemasphere…
    • Luca Castagna
    • Massimo Magagnoli
    • Rita Mazza
    • Lucia Morello
    • Francesca Ricci
    • Stefania Bramanti
    • Barbara Sarina
    • Jacopo Mariotti
    • Chiara De Philippis
    • Simona Sica
    • Marcello Rodari
    • Martina Sollini
    • Margarita Kirienko
    • Arturo Chiti
    • Armando Santoro
    • Carmelo Carlo-Stella
  • P104 (0004)
    Nivolumab in relapsed/refractory classic Hodgkin lymphoma: Experience with ten patients
    View full abstract at Hemasphere…
    • Reyad Dada
    • Yazeed Zabani
  • P106 (0131)
    Clinical benefit of Nivolumab in Hodgkin Lymphoma but at what price? Example into a Paris University Hospital
    View full abstract at Hemasphere…
    • E. Peyrilles
    • I. Madelaine
    • C. Thieblemont
    • P. Brice
  • P107 (0155)
    Pembrolizumab Monotherapy in Relapsed/Refractory Classic Hodgkin Lymphoma: Updated Efficacy and Safety Analysis of the Phase 2 KEYNOTE-087 Study
    • Pier Luigi Zinzani
    • Robert Chen
    • Philippe Armand
    • Nathalie Johnson
    • Pauline Brice
    • John Radford
    • Vincent Ribrag
    • Daniel Molin
    • Theodoros P. Vassilakopoulos
    • Akihiro Tomita
    • Bastian Von Tresckow
    • Margaret A. Shipp
    • Eunhee Kim
    • Akash Nahar
    • Arun Balakumaran
    • Craig H. Moskowitz

Relapsed/Refractory

  • T029 (0010)
    Second Autologous Stem Cell Transplantation (ASCT) for Relapsed or Refractory (R/R) Hodgkin Lymphoma (HL) after a Previous Autograft: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
    Abstract Talk in Relapsed/Refractory HL (Monday 16:00–17:30)
    • Carmen Martínez
    • Ariane Boumendil
    • Joanna Romejko-Jarosinska
    • Achilles Anagnostopoulos
    • Edgar Faber
    • Xavier Poiré
    • Ibrahim Yakoub-Agha
    • Saad Akhtar
    • Gunhan Gurman
    • Vincenzo Pavone
    • Kazimierz Halaburda
    • Aida Botelho Sousa
    • Gilles Salles
    • Hervé Finel
    • Irma Khvedelidze
    • Silvia Montoto
    • and Anna Sureda
  • T030 (0103)
    Bendamustine, Gemcitabine, and Dexamethasone (BGD) Chemotherapy Followed by Autologous Stem Cell Transplantation (ASCT) Is Effective Treatment for Patients with Relapsed/Refractory Hodgkin Lymphoma (rHL) – Results of the Polish Lymphoma Research Group
    Abstract Talk in Relapsed/Refractory HL (Monday 16:00–17:30)
    View full abstract at Hemasphere…
    • Ewa Paszkiewicz-Kozik
    • Agata Tyczynska
    • Martyna Kotarska
    • Marcin Szymanski
    • Lukasz Targonski
    • Joanna Drozd-Sokolowska
    • Justyna Rybka
    • Elzbieta Wojciechowska-Lampka
    • Joanna Tajer
    • Lidia Poplawska
    • Joanna Romejko-Jarosinska
    • Michal Osowiecki
    • Sebastian Rybski
    • Jan Zaucha
    • Jan Walewski
  • P118 (0068)
    Long Term Safety and Efficacy of Combination of Brentuximab Vedotin and Ipilimumab or Nivolumab in Relapsed / Refractory Hodgkin Lymphoma: A trial of the ECOG-ACRIN Cancer Research Group (E4412)
    Poster Pitch in Relapsed/Refractory HL (Monday 16:00–17:30)
    • Catherine S. Diefenbach
    • Fangxin Hong
    • Richard F. Ambinder
    • Jonathon B. Cohen
    • Michael J. Robertson
    • Kevin A. David
    • Ranjana H. Advani
    • Timothy S. Fenske
    • Stefan K. Barta
    • Neil D. Palmisano
    • Jakub Svoboda
    • David S. Morgan
    • Reem Karmali
    • Brad S. Kahl
    • Steven M. Ansell
  • P126 (0121)
    PD-1 blockade for Hodgkin Lymphoma after Allogeneic Stem Cell Transplantation
    Poster Pitch in Relapsed/Refractory HL (Monday 16:00–17:30)
    View full abstract at Hemasphere…
    • Julia Meissner
    • Sascha Dietrich
    • Anna Sureda
    • Herve Finel
    • Irma Khvedelidze
    • Luca Castagna
    • Noël Milpied
    • Herve Ghesquieres
    • Ron Ram
    • Ali Bazarbachi
    • Roch Houot
    • Georg Maschmeyer
    • Domenico Russo
    • Jakob Passweg
    • Alexandros Spyridonidis
    • Michael Stadler
    • Stephen Robinson
    • Peter Dreger
    • Silvia Montoto
  • T031 (0110)
    Five-Year Progression-Free Survival Outcomes From a Pivotal Phase 3 Study of Consolidative Brentuximab Vedotin After Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma at Risk of Relapse or Progression (AETHERA).
    Abstract Talk in Relapsed/Refractory HL (Monday 16:00–17:30)
    View full abstract at Hemasphere…
    • Craig H. Moskowitz
    • Jan Walewski
    • Auayporn Nademanee
    • Tamas Masszi
    • Edward Agura
    • Jerzy Holowiecki
    • Muneer H. Abidi
    • Andy I. Chen
    • Patrick Stiff
    • Simonetta Viviani
    • Veronika Bachanova
    • Anna Sureda
    • Teresa McClendon
    • Connie Lee
    • Julie Lisano
    • and John Sweetenham
  • T032 (0130)
    Relapse after Early-Stage Favorable Hodgkin Lymphoma: Disease Characteristics, Treatment Strategies and their Outcome
    Abstract Talk in Relapsed/Refractory HL (Monday 16:00–17:30)
    View full abstract at Hemasphere…
    • Paul J. Bröckelmann
    • Horst Müller
    • Teresa Guhl
    • Karolin Behringer
    • Michael Fuchs
    • Bastian von Tresckow
    • Peter Borchmann
    • Andreas Engert
  • P067 (0166)
    VERY LATE RELAPSES (VLRS) IN HODGKIN LYMPHOMA (HL) OCCURING ≥5 YEARS AFTER INITIAL TREATMENT WITH CHEMOTHERAPY ± RADIOTHERAPY (CT±RT): PATTERN OF RISK OVER 35 YEARS AND THE SIGNIFICANCE OF HISTOLOGY
    View full abstract at Hemasphere…
    • Theodoros P. Vassilakopoulos
    • Maria K. Angelopoulou
    • Euridiki Kravariti
    • Maria N. Dimopoulou
    • Marina P. Siakantaris
    • Athanasios Liaskas
    • Gabriela Gainaru
    • Ioannis Assimakopoulos
    • Maria Arapaki
    • Panagiotis Diamantopoulos
    • Ilianna Konstantinou
    • Georgios Boutsikas
    • Kyriaki Petevi
    • Alexandros Kanellopoulos
    • Theofanis Giannikos
    • Chrisovalanti Chatzidimitriou
    • Maria Efstathopoulou
    • Maria Dimou
    • Maria Moschogiannis
    • Xanthi Giakoumis
    • Ilias Pessach
    • Sotirios Sachanas
    • Theo
  • P108 (0001)
    Allogeneic stem cell transplantation after treatment with checkpoint inhibitors: feasibility and safety in pooled analysis
    View full abstract at Hemasphere…
    • Reyad Dada
    • Binyam Usman
  • P109 (0012)
    High CR rate in Interim Results of a phase II trial of Nivolumab with or without ICE in relapsed/refractory HL prior to AHCT
    • Robert Chen
    • Joycelynne Palmer
    • Alex Herrera
    • Hun Lee
    • Nicole Tsai
    • Joo Song
    • Kathryn McBride
    • Matthew Mei
    • Jasmin Zain
    • Leslie Popplewell
    • Auayporn Nademanee
    • Steven Rosen
    • Larry Kwak
    • and Stephen Forman
  • P110 (0014)
    Successful treatment of Hodgkin lymphoma with brentuximab vedotin relapsing after autologous stem cell transplantation
    View full abstract at Hemasphere…
    • Markova J
    • Mocikova H
    • Gaherova L
    • Kozak T. On behalf of the Czech Hodgkin Lymphoma Study Group
  • P111 (0017)
    Time to relapse in nodular lymphocyte-predominant Hodgkin lymphoma is related to the histopathological pattern at initial diagnosis and relapse
    • Sylvia Hartmann
    • Bianca Schuhmacher
    • Annette Plütschow
    • Julia Bein
    • Anja Mottok
    • Heinz-Wolfram Bernd
    • Alfred C. Feller
    • German Ott
    • Sergio Cogliatti
    • Michael Hummel
    • Falko Fend
    • Leticia Quintanilla-Martinez
    • Harald Stein
    • Wolfram Klapper
    • Peter Möller
    • Ralf Küppers
    • Andreas Rosenwald
    • Andreas Engert
    • Martin-Leo Hansmann
    • Dennis A. Eichenauer
  • P112 (0020)
    A PHASE II STUDY WITH BENDAMUSTINE PLUS BRENTUXIMAB VEDOTIN IN HODGKIN’S LYMPHOMA IN FIRST SALVAGE SETTING: THE BBV REGIMEN.
    • Alessandro Broccoli
    • Barbara Botto
    • Paolo Corradini
    • Antonello Pinto
    • Alessandro Re
    • Marina Cesaretti
    • Lisa Argnani
    • Umberto Vitolo
    • Pier Luigi Zinzani
  • P113 (0040)
    Phase I/II study of Brentuximab Vedotin in first refractory/relapsed classical Hodgkin lymphoma patients treated by chemotherapy (ICE) before autologous transplantation.
    View full abstract at Hemasphere…
    • Aspasia Stamatoullas
    • Hervé Ghesquieres
    • Aurore Perrot
    • Philippe Quittet
    • Franck Morschhauser
    • Vincent Ribrag
    • Veronique Edeline
    • and Pauline Brice
    • for the LYSA group
  • P114 (0041)
    Results of Mini-BEAM as second salvage chemotherapy after DHAP based chemotherapy for relapsed or refractory classical Hodgkin lymphoma
    View full abstract at Hemasphere…
    • Veldman C
    • Nijland M
    • van Meerten T
    • Hoogendoorn M
    • Huls GW
    • Plattel WJ
  • P115 (0048)
    Brentuximab vedotin (BV) as maintenance or salvage therapy after ASCT for relapsed/refractory (R/R) HL
    View full abstract at Hemasphere…
    • Kameliya Milcheva
    • Yavor Petrov
    • Emilia Naseva
    • Penka Ganeva
    • Kalina Ignatova
    • Georgi Aranaudov and Branimir Spasov
  • P116 (0054)
    EARLY TRANSPLANT RELATED COMPLICATIONS IN HODGKIN LYMPHOMA PATIENTS RECEIVING PD-1 INHIBITORS BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION
    View full abstract at Hemasphere…
    • Chiara de Philippis
    • Jacopo Mariotti
    • Stefania Bramanti
    • Barbara Sarina
    • Massimo Magagnoli
    • Lucia Morello
    • Armando Santoro
    • Carmelo Carlo-Stella and Luca Castagna.
  • P117 (0063)
    BENDAMUSTINE IN HEAVILY PRE-TREATED HODGKIN LYMPHOMA PATIENTS
    View full abstract at Hemasphere…
    • Pavlov V.V.
    • Falaleeva N.A.
    • Bogatyreva T.I.
    • Shklyaev S.S.
    • Terekhova A.Yu.
    • Volodina O.M.
  • P119 (0078)
    Real life data of brentuximab vedotin use in relapsed/refractory HL in Sweden
    View full abstract at Hemasphere…
    • Christine Jansson
    • Ingemar Lagerlöf
    • Johan Linderoth
    • Ann-Sofie Johansson
    • Fredrik Ellin
    • Marzia Palma
    • Urban Jerlström
    • Karin E. Smedby
    • Daniel Molin
  • P120 (0086)
    Outcomes and Toxicities after Brentuximab vedotin (BV) Maintenance in Relapsed/Refractory Hodgkin Lymphoma Patient Exposed to BV prior to Autologous Hematopoietic Stem Cell Transplant
    View full abstract at Hemasphere…
    • Gunjan L. Shah MD MS
    • Alison J. Moskowitz MD
    • Sridevi Rajvee MBBS
    • Susan J. McCall MSN ANP-BC
    • Molly A. Maloy MS
    • Craig Sauter MD
    • Sergio A. Giralt MD
    • Matthew J. Matasar MD MS
    • Craig H. Moskowitz MD
  • P121 (0089)
    Sequential time-intensified brentuximab vedotin (BV) followed by gemcitabine, vinorelbine and pegylated liposomal doxorubicine (GVD) as a bridge to autologous transplantation in DHAP resistant relapsed or refractory CD30+ lymphoma
    View full abstract at Hemasphere…
    • Skirmante Cernauskiene
    • Ruta Semaskeviciene
    • Orinta Mickeviciute
    • Laimonas Griskevicius
  • P122 (0090)
    BRENTUXIMAB VEDOTIN PRIOR TO ALLOGENEIC TRANSPLANTATION IN HODGKIN’S LYMPHOMAS REDUCES CHRONIC GVHD WITHOUT WORSENING THE OUTCOME
    View full abstract at Hemasphere…
    • Francesco Gaudio
    • Patrizio Mazza
    • Angelo Michele Carella
    • Anna Mele
    • Giulia Palazzo
    • Giovanni Pisapia
    • Paola Carluccio
    • Domenico Pastore
    • Nicola Cascavilla
    • Giorgina Specchia
    • Vincenzo Pavone
  • P123 (0107)
    Next generation sequencing-based clonality assessment of immunoglobulin gene rearrangements distinguishes relapse from second primary Hodgkin lymphoma
    View full abstract at Hemasphere…
    • Diede van Bladel
    • MSc
    • Michiel van den Brand
    • MD PhD
    • Jos Rijntjes
    • BSc
    • Arjen Brinkman
    • PhD
    • Tomas Reigl
    • Nikos Darzentas
    • Corine Hess
    • Konnie Hebeda
    • Han van Krieken
    • Patricia Groenen
    • Blanca Scheijen
  • P124 (0115)
    RETROSPECTIVE REAL-LIFE STUDY OF THE BEGEV (BENDAMUSTINE, GEMCITABINE, VINORELBINE) REGIMEN IN HEAVILY PRETREATED, RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA PATIENTS
    View full abstract at Hemasphere…
    • Antonio Russo
    • Alessandro Pulsoni
    • Francesca Ricci
    • Rita Mazza
    • Massimo Magagnoli
    • Lucia Morello
    • Marcello Rodari
    • Alessandra Serrao
    • Giorgia Annechini
    • Andrea Nervini
    • Laura Giordano
    • Luca Castagna
    • Arturo Chiti
    • Armando Santoro
    • Carmelo Carlo-Stella
  • P125 (0116)
    Nivolumab Re-Treatment in Patients With Relapsed/Refractory Hodgkin Lymphoma
    View full abstract at Hemasphere…
    • Stephen M. Ansell
    • Philippe Armand
    • John M. Timmerman
    • Margaret A. Shipp
    • Ulrich Jäger
    • Wolfgang Willenbacher
    • Rao Saleem
    • Julia He
    • Mariana Sacchi
    • Anne Sumbul
    • Alexander M. Lesokhin
  • P127 (0126)
    Autologous (auto-HCT) and Allogeneic Stem Cell Transplantation (allo-HCT) in the Management of Relapsed/Refractory (RR) Hodgkin Lymphoma (HL). A Retrospective Analysis of the Lymphoma Working Party of the EBMT.
    View full abstract at Hemasphere…
    • Anna Sureda
    • Sonja Genadieva-Stavrik
    • Ariane Boumendil
    • Herve Finel
    • Irma Khvedelidze
    • Sascha Dietricht
    • Peter Dreger
    • Olivier Hermine
    • Chara Kyriakou
    • Stephen Robinson
    • Norbert Schmitz
    • Harry Schouten
    • Alina Tanase
    • Silvia Montoto
  • P128 (0127)
    SUCCESFUL SLOW DESENSITIZATION TO BRENTUXIMAB VEDOTIN AFTER ANAPHYLAXIS: 3 CASE REPORTS IN THE BASQUE AUTONOMOUS COMMUNITY
    View full abstract at Hemasphere…
    • Otero Longo Itziar
    • Aranbarri Larrañaga Ane
    • Caminos Altuna Nerea
    • Martinez Molina Sara
    • Joral Badas Alejandro
    • Ondarra Segurola Laida
    • Lombardi Iglesias Clara
    • Diez Angulo Rosa Ana
    • Olabarria Santurtun Iciar
    • Araiz Ramirez Maria
    • Ceberio Echechipia Izaskun
  • P129 (0128)
    Clinical analysis of relapse patterns in Hodgkin Lymphoma
    View full abstract at Hemasphere…
    • Oertel M
    • Kriz J
    • Kerkhoff A
    • Reusch J
    • Kröger K
    • Elsayad K
    • Haverkamp U
    • Lenz G
    • Eich HT
  • P130 (0132)
    PRIMARY PROGRESSIVE CLASSICAL HODGKIN LYMPHOMA – A SINGLE CENTRE EXPERIENCE
    View full abstract at Hemasphere…
    • C. Afonso
    • A. Roque
    • D. Neves
    • A. Pinto
    • D. Mota
    • R. Guilherme
    • M. Gomes
    • L. Ribeiro
  • P131 (0133)
    Pooled results of two annual cohorts from an observational prospective study describing brentuximab vedotin use in routine practice in France for Hodgkin Lymphoma: Interim analysis.
    • Sibon David
    • Quittet Philippe
    • Borel Cécile
    • Stamatoullas Aspasia
    • Franchi-Rezgui Patricia
    • Ghesquières Hervé
    • Dulery Rémy
    • Benbrahim Omar
    • Hammoud Mohammad
    • Filliatre-Clément Lauriane
    • De Guibert Sophie
    • Coulibaly Colombe
    • Casasnovas Olivier
    • Bouabdallah Réda
    • and Brice Pauline
    • for ODICE study group
  • P132 (0138)
    Patterns and Outcomes with Salvage Treatment for Hodgkin Lymphoma (HL) in the Modern Era: A Real-World Analysis from the Community Oncology Setting in the United States
    View full abstract at Hemasphere…
    • AJ Kumar
    • CR Chao
    • AM Rodday
    • NT Cannizzaro
    • R Rodriguez
    • J Feliciano
    • AM Evens
    • SK Parsons
  • P133 (0148)
    PROGNOSTIC VALUE OF (18) F-FLUORODEOXYGLUCOSE-POSITRON EMISION TOMOGRAPHY ON SURVIVAL IN HODGKIN LYMPHOMA PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION.
    View full abstract at Hemasphere…
    • Eva Domingo-Domènech
    • Carmen Martínez
    • M. del Pilar Perlaza
    • Montserrat Cortes
    • Gonzalo Gutiérrez
    • Rocio Parody
    • María Suárez-Lledó
    • Francesc Fernández-Avilés
    • Isabel Sanchez-Ortega
    • Montserrat Rovira
    • Xavier Setoain
    • Valentín Ortíz
    • Anna Sureda
  • P134 (0156)
    Induction therapy with everolimus in combination with DHAP (Dexamethasone, High-Dose AraC, Cisplatinum) in patients with relapsed or refractory classical Hodgkin lymphoma: a randomized, placebo-controlled phase I/II trial (HD-R3i)
    View full abstract at Hemasphere…
    • Bastian von Tresckow
    • Andreas Hüttman
    • Vladan Vucinic
    • Horst Müller
    • Annette Pluetschow
    • Andreas Viardot
    • Max S. Topp
    • Carsten Kobe
    • Boris Böll
    • Dennis A. Eichenauer
    • Stephanie Sasse
    • Heinz Haverkamp
    • Michael Fuchs
    • Andreas Engert and Peter Borchmann
  • P135 (0160)
    Brentuximab-Vedotin + Bendamustine : a highly effective salvage treatment un refractory/relapsed patients with Hodgkin Lymphoma
    View full abstract at Hemasphere…
    • D. Martineau
    • M. Sauvezie
    • L. Oberic
    • A. Mazari
    • A. Banos
    • F. Bijou
    • P. Brice
    • Thyss
    • AC Gac
    • E. Gyan
    • N. Milpied
    • K. Bouabdallah
  • P136 (0161)
    Long term outcome of patients with relapsed / refractory Hodgkin lymphoma treated at a single institution over 25 years
    View full abstract at Hemasphere…
    • Joanna Romejko-Jarosinska
    • Ewa Paszkiewicz-Kozik
    • Joanna Tajer
    • Elzbieta Wojciechowska-Lampka
    • Martyna Kotarska
    • Anna Borawska
    • Lidia Poplawska
    • Katarzyna Domanska-Czyz
    • Beata Ostrowska
    • Wlodzimirz Osiadacz
    • Michal Osowiecki
    • Anna Dabrowska=Iwanicka
    • Monika Swierkowska
    • Lukasz Targonski
    • Marcin Szymanski
    • Robert Konecki
    • Jan Walewski
  • P137 (0165)
    TREATMENT STRATEGIES AND PROGNOSTIC FACTORS FOR THE OUTCOME OF VERY LATE RELAPSES (VLRs) OCCURRING ≥5 YEARS AFTER INITIAL TREATMENT WITH CHEMOTHERAPY ± RADIOTHERAPY (CT±RT) IN HODGKIN LYMPHOMA (HL): A JOINT STUDY FROM THE UNIVERSITY OF ATHENS AND ISTITUTO
    View full abstract at Hemasphere…
    • Theodoros P. Vassilakopoulos
    • Athanasios Liaskas
    • Giuliana Rizzuto
    • Maria K. Angelopoulou
    • Maria N. Dimopoulou
    • Alberto Mussetti
    • Marina P. Siakantaris
    • Ioannis Assimakopoulos
    • Maria Arapaki
    • Penelope Korkolopoulou
    • Antonello Cabras
    • George Rassidakis
    • Maria Dimou
    • Eleni Variami
    • Panagiotis Panagiotidis
    • Paolo Corradini
    • Kostas Konstantopoulos
    • Gerassimos A. Pangalis
    • Simonetta Viviani
    • TPV and AL had equal contribution to this work.
  • P138 (0167)
    Long-term High Dose Chemotherapy Before Hematopoietic Stem Cell Transplantation due to Restricted Access to New Therapies
    View full abstract at Hemasphere…
    • Tito Vanelli
    • Gueverson Rocha
    • Caroline Brum
    • Marcelo Capra
    • Elisa Schneider
    • Tahiane Soares
    • Gustavo Fischer
    • Luis Contin
    • Samira Fiorot Lodi
    • Geovana Botan
    • Laura Fogliato
  • P139 (0169)
    Brentuximab vedotin alone and in combination with bendamustine as salvage therapy for primary refractory or relapsed Hodgkin lymphoma: multicentre experience of the Polish Lymphoma Research Group
    View full abstract at Hemasphere…
    • Czyz A.
    • Lojko-Dankowska A.
    • Joks M.
    • Komarnicki M.
    • Dlugosz-Danecka M.
    • Jurczak W.
    • Rybka J.
    • Wrobel T.
    • Paszkiewicz E.
    • Walewski J.
    • Hawrylecka D.
    • Drozd-Sokolowska J.
    • Subocz E.
    • Szymanska A.
    • Witkowska M.
    • Smolewski P.
    • Giebel S.
    • Zaucha J.M.

ISHL11 Award Winners

Young Investigator Award

  • Annika Weiß (0158)
  • Valeria Fiaccadori (0066)
  • Nele Stadtbäumer (0122)
  • Ryan Lynch (0044)
  • Justine Kahn (0042)

KARL MUSSHOFF PRIZE: BASIC AND TRANSLATIONAL SCIENCE

  • Ralf Küppers

KARL MUSSHOFF PRIZE: CLINICAL RESEARCH

  • Richard Hoppe

ISHL11 Abstract Book

ISHL11 Abstract Book